Skip to main content

Front Row Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1729254 TIBURON, CA

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,107
-$209 QoQ
Shares Held
7
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#736
of 784 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Front Row Advisors LLC holds $551,277 across 11 Biotechnology names. ALNY ranks #5 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ALNY
Alnylam Pharmaceuticals, Inc.
This page
7 $2,107

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,107 7
2026-03-31 $2,316 7
2025-12-31 $2,783 7
2025-09-30 $3,192 7
2025-06-30 $2,934 9
2025-03-31 $3,780 14
2024-12-31 $3,294 14
2024-09-30 $3,850 14
2024-06-30 $3,402 14
2024-03-31 $2,092 14
2023-12-31 $2,679 14
2023-09-30 $2,479 14
2023-06-30 $3 14
2023-03-31 $2,804 14
2022-09-30 $2,802 14
2022-06-30 $2,041 14
2022-03-31 $2,286 14
2021-12-31 $2,374 14
2021-09-30 $2,643 14
2021-06-30 $2,373 14
2021-03-31 $1,976 14
2020-12-31 $1,819 14
2020-09-30 $2,038 14
2020-06-30 $2,073 14
2020-03-31 $1,523 14